×
Sustained Symptomatic Remission and Recovery and Their Loss Among Patients With Borderline Personality Disorder and Patients With Other Types of Personality Disorders: A 24-Year Prospective Follow-Up Study PDF
$ 40.00
Sustained Symptomatic Remission and Recovery and Their Loss Among Patients With Borderline Personality Disorder and Patients With Other Types of Personality Disorders: A 24-Year Prospective Follow-Up Study PDF quantity
$ 40.00
×
Co-occurrence of Sexsomnia and Dhat Syndrome in an Adolescent Male PDF
$ 40.00
Co-occurrence of Sexsomnia and Dhat Syndrome in an Adolescent Male PDF quantity
$ 40.00
×
Pharmacologic Treatment of Tardive Dyskinesia: A Meta-Analysis and Systematic Review PDF
$ 40.00
Pharmacologic Treatment of Tardive Dyskinesia: A Meta-Analysis and Systematic Review PDF quantity
$ 40.00
×
When Lorazepam Worsens Delirium in Your Catatonic Patient PDF
$ 40.00
When Lorazepam Worsens Delirium in Your Catatonic Patient PDF quantity
$ 40.00
×
Catatonic Coma in a Patient With Schizophrenia Receiving Palliative Care With Reversal of Symptoms With Lorazepam PDF
$ 40.00
Catatonic Coma in a Patient With Schizophrenia Receiving Palliative Care With Reversal of Symptoms With Lorazepam PDF quantity
$ 40.00
×
Psychological Resilience, Coping, and Distress in Admitted Patients With COVID-19 Infection PDF
$ 40.00
Psychological Resilience, Coping, and Distress in Admitted Patients With COVID-19 Infection PDF quantity
$ 40.00
×
Interactions of Borderline Personality Disorder and Mood Disorders Over 10 Years PDF
$ 40.00
Interactions of Borderline Personality Disorder and Mood Disorders Over 10 Years PDF quantity
$ 40.00
×
Delayed Diagnosis of Glioblastoma Multiforme Presenting With Atypical Psychiatric Symptoms PDF
$ 40.00
Delayed Diagnosis of Glioblastoma Multiforme Presenting With Atypical Psychiatric Symptoms PDF quantity
$ 40.00
×
Screening, Assessment, and Pharmacologic Treatment of Mild Cognitive Impairment and Early Alzheimer’s Disease: The Role for Monoclonal Antibodies PDF
$ 40.00
Screening, Assessment, and Pharmacologic Treatment of Mild Cognitive Impairment and Early Alzheimer’s Disease: The Role for Monoclonal Antibodies PDF quantity
$ 40.00
Coupon: Apply coupon
Update cart